Total Payments
$1,670
2023 Payments
$19.43
Companies
19
Transactions
29
Medicare Patients
2,534
Medicare Billing
$472,424
Payment Breakdown by Category
Consulting$1,125 (67.4%)
Food & Beverage$532.67 (31.9%)
Education$12.29 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,125 | 1 | 67.4% |
| Food and Beverage | $532.67 | 27 | 31.9% |
| Education | $12.29 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $1,141 | 2 | $0 (2021) |
| Amgen Inc. | $57.61 | 2 | $0 (2020) |
| Janssen Biotech, Inc. | $56.66 | 2 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $55.75 | 3 | $0 (2018) |
| GlaxoSmithKline, LLC. | $54.28 | 2 | $0 (2020) |
| Lilly USA, LLC | $44.75 | 4 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $29.45 | 2 | $0 (2019) |
| EMD Serono, Inc. | $29.12 | 1 | $0 (2020) |
| Pharmacyclics LLC, An AbbVie Company | $28.98 | 1 | $0 (2021) |
| BeiGene USA, Inc. | $23.07 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $19.43 | 1 | Intuitive Surgical, Inc. ($19.43) |
| 2021 | $1,202 | 5 | Celgene Corporation ($1,125) |
| 2020 | $219.50 | 10 | Amgen Inc. ($57.61) |
| 2019 | $58.42 | 3 | Merck Sharp & Dohme Corporation ($29.45) |
| 2018 | $117.50 | 7 | Novartis Pharmaceuticals Corporation ($34.58) |
| 2017 | $52.66 | 3 | Novartis Pharmaceuticals Corporation ($21.17) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/21/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: SURGERY | ||||||
| 08/26/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: ONCOLOGY | ||||||
| 07/06/2021 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Oncology | ||||||
| 06/04/2021 | Celgene Corporation | REBLOZYL (Biological) | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| Category: Hematology | ||||||
| 03/17/2021 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Oncology | ||||||
| 02/25/2021 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $16.24 | General |
| 12/17/2020 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Oncology | ||||||
| 12/10/2020 | Amgen Inc. | Nplate (Biological) | Food and Beverage | In-kind items and services | $37.29 | General |
| Category: Hematology | ||||||
| 10/08/2020 | EMD Serono, Inc. | Bavencio (Drug) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: Oncology | ||||||
| 09/29/2020 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2020 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Oncology | ||||||
| 08/26/2020 | Amgen Inc. | Prolia (Biological), XGEVA | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Bone Health | ||||||
| 08/04/2020 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: ONCOLOGY | ||||||
| 02/25/2020 | Lilly USA, LLC | ALIMTA (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Oncology | ||||||
| 02/25/2020 | Lilly USA, LLC | ALIMTA (Drug) | Food and Beverage | In-kind items and services | $3.71 | General |
| Category: Oncology | ||||||
| 02/25/2020 | Lilly USA, LLC | ALIMTA (Drug) | Food and Beverage | In-kind items and services | $2.18 | General |
| Category: Oncology | ||||||
| 12/04/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $16.21 | General |
| 10/22/2019 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: Oncology | ||||||
| 04/18/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Oncology | ||||||
| 07/10/2018 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: ONCOLOGY | ||||||
| 05/22/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 05/16/2018 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Oncology | ||||||
| 04/03/2018 | Novartis Pharmaceuticals Corporation | SANDOSTATIN LAR (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2018 | Janssen Scientific Affairs, LLC | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 38 | 41 | $5,527 | $1,515 |
| 2022 | 8 | 377 | 470 | $137,956 | $40,521 |
| 2021 | 16 | 1,079 | 19,487 | $465,614 | $168,662 |
| 2020 | 17 | 1,040 | 19,496 | $748,917 | $261,726 |
Total Patients
2,534
Total Services
39,494
Medicare Billing
$472,424
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 11 | 12 | $4,628 | $1,295 | 28.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 27 | 29 | $899.00 | $220.69 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 133 | $37,905 | $12,805 | 33.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 73 | 73 | $31,755 | $8,729 | 27.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 87 | 87 | $24,969 | $5,738 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 90 | $17,550 | $5,560 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 22 | $8,426 | $3,248 | 38.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $7,111 | $2,393 | 33.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $9,000 | $1,740 | 19.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 30 | 40 | $1,240 | $307.92 | 24.8% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2021 | 132 | 669 | $267,360 | $107,040 | 40.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 227 | 300 | $57,678 | $18,615 | 32.3% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2021 | 19 | 16,830 | $33,660 | $12,669 | 37.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 84 | 84 | $24,108 | $7,458 | 30.9% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 17 | 44 | $18,172 | $5,040 | 27.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 55 | $15,552 | $4,840 | 31.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 31 | 68 | $12,716 | $3,726 | 29.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 215 | 473 | $13,739 | $3,660 | 26.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $4,789 | $1,473 | 30.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 205 | 433 | $3,897 | $1,296 | 33.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 16 | 86 | $5,762 | $975.60 | 16.9% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2021 | 14 | 35 | $3,605 | $894.20 | 24.8% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 26 | 47 | $3,102 | $617.97 | 19.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 20 | 22 | $864.00 | $232.32 | 26.9% |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | Office | 2021 | 16 | 28 | $308.00 | $89.12 | 28.9% |
About Dr. Manoel Moraes, MD
Dr. Manoel Moraes, MD is a Medical Oncology healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114996170.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manoel Moraes, MD has received a total of $1,670 in payments from pharmaceutical and medical device companies, with $19.43 received in 2023. These payments were reported across 29 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($1,125).
As a Medicare-enrolled provider, Moraes has provided services to 2,534 Medicare beneficiaries, totaling 39,494 services with total Medicare billing of $472,424. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Other Specialties Medical Oncology
- Location Fort Myers, FL
- Active Since 03/14/2006
- Last Updated 12/14/2023
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1114996170
Products in Payments
- REBLOZYL (Biological) $1,125
- IMBRUVICA (Drug) $56.67
- ZEJULA (Drug) $54.28
- DARZALEX (Biological) $39.97
- Nplate (Biological) $37.29
- Bavencio (Drug) $29.12
- ALIMTA (Drug) $27.73
- SANDOSTATIN LAR (Drug) $23.15
- BRUKINSA (Drug) $23.07
- LYNPARZA (Drug) $22.10
- Cabometyx (Drug) $20.95
- Prolia (Biological) $20.32
- Da Vinci Surgical System (Device) $19.43
- VERZENIO (Drug) $17.02
- SYNDROS (Drug) $16.58
- Venclexta (Drug) $15.66
- Nubeqa (Drug) $15.21
- KEYTRUDA (Biological) $13.24
- ADCETRIS (Biological) $12.29
- MEKINIST (Drug) $11.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Fort Myers
Dr. Lowell Hart, M.d, M.D
Medical Oncology — Payments: $402,512
Medical Oncology $402,512
Dr. James Reeves, M.d, M.D
Medical Oncology — Payments: $198,428
Medical Oncology $198,428
Dr. Michael Mccleod, Do, DO
Medical Oncology — Payments: $63,904
Medical Oncology $63,904
Dr. Vitor Pastorini Filho, M.d, M.D
Medical Oncology — Payments: $18,036
Medical Oncology $18,036
Dr. Van Rana, 09221980, 09221980
Medical Oncology — Payments: $9,740
Medical Oncology $9,740
Venkata Parsa, Md, MD
Medical Oncology — Payments: $1,888
Medical Oncology $1,888